[Back to Number 9 ToC] [Back to Journal Contents] [Back to Biokhimiya Home page]

Structure and Folding of Bacteriophage T4 Gene Product 9 Triggering Infection. II. Study of Conformational Changes of Gene Product 9 Mutants Using Monoclonal Antibodies

L. V. Zhemaeva, N. N. Sykilinda, G. A. Navruzbekov, L. P. Kurochkina, and V. V. Mesyanzhinov*

Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, Moscow, 117871 Russia; fax: (095) 336-6022; E-mail: vvm@ibch.siobc.ras.ru

* To whom correspondence should be addressed.

Received January 13, 2000; Revision received February 16, 2000
Gene product 9 (gp9) of bacteriophage T4, whose spatial structure we have recently solved to 2.3 Å resolution, is a convenient model for studying the folding and oligomerization mechanisms of complex proteins. The gp9 polypeptide chain consists of 288 amino acids forming three domains. Three monomers, packed in parallel, assemble to a functionally active protein. The main aim of this work was to study conformational changes and trimerization of gp9 deletion mutants using monoclonal antibodies (mAbs). We selected a set of mAbs interacting with the amino, middle, and carboxyl regions of the protein, respectively. Eighteen mAbs bind to native as well as to denatured protein, and two mAbs bind to denatured protein only. Using mAbs, we found that deletions of the gp9 N-terminal region result in conformational changes in the middle and C-terminal domains. The study of mAb binding to the CDelta. truncated mutant by competitive ELISA and immunoblotting shows that the C-terminus of the gp9 sequence is essential for protein trimerization and stability. A single point substitution of the Gln282 residue causes formation of a labile trimer that has significant conformational changes in the protein domains. The results of our study show that folding and trimerization of gp9 is a cooperative process that involves all domains of the protein.
KEY WORDS: bacteriophage T4, baseplate, gene product 9, protein folding, monoclonal antibody